About HPGC Renmintongtai Pharmaceutical Corporation Company

The company changed its name from Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. after a major asset restructuring in April 2015. The company's stock code is “600829,” and the controlling shareholder of the company is Harbin Pharmaceutical Group Co., Ltd. The company currently has two wholly-owned subsidiaries, Harbin Pharmaceutical Group Pharmaceutical Co., Ltd. and Harbin Pharmaceutical Group Sanjing Hospital Investment Management Co., Ltd., which are mainly engaged in pharmaceutical wholesale and retail business. It is a well-known domestic pharmaceutical distribution enterprise and a leading pharmaceutical business in Heilongjiang Province. It mainly engages in pharmaceutical wholesale business, pharmaceutical retail business, and provides pharmaceutical logistics services and medical services. The company mainly sells chemicals, proprietary Chinese medicines, biological products, and also sells medical devices, traditional Chinese medicine tablets, health products, daily necessities, glass instruments, chemical reagents, etc. The company has received honors such as advanced grass-roots trade unions, supporting advanced units in old districts, the Best Design Award, Excellent Quality Management Group Activities, the 2010 Major Tax Contributor, and the 2020 Honest Construction Demonstration Unit.